AIM IMMUNOTECH INC. Stock Issued During Period, Shares, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- AIM IMMUNOTECH INC. stock issued during period, shares, new issues for the quarter ending 2023-09-30 was 315.12K shares.
- AIM IMMUNOTECH INC. stock issued during period, shares, new issues for the quarter ending 2023-06-30 was 10.97K shares.
- AIM IMMUNOTECH INC. stock issued during period, shares, new issues for the quarter ending 2023-03-31 was 969.00 shares.
- AIM IMMUNOTECH INC. stock issued during period, shares, new issues for the quarter ending 2015-03-31 was 2.05M shares.
- AIM IMMUNOTECH INC. stock issued during period, shares, new issues for fiscal 2010 was 520.00K shares.
| Period end | Stock Issued During Period, Shares, New Issues 3 month | Stock Issued During Period, Shares, New Issues 12 month |
|---|---|---|
| 2023-09-30 | 315.12K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | |
| 2023-06-30 | 10.97K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | |
| 2023-03-31 | 969.00 shares 10-Q · filed 2023-05-15 | |
| 2015-03-31 | 2.05M shares 10-Q · filed 2025-05-15 | |
| 2010-12-31 | 520.00K shares 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |